Breaking News

CordenPharma Expands Peptide Development Capacity

Increases CoE for peptide development capacity to support European domestic growth.

By: Contract Pharma

Contract Pharma Staff

CordenPharma’s Centre of Excellence for Peptide Process Development and non-GMP manufacturing in Frankfurt, Germany is not only known for bringing a high level of peptide expertise in the development of efficient and lean peptide processes like Glucagon-Like Peptide analogues (GLP 1 or GLP 2), but also for being able to tackle challenging projects such as branched or sophisticated multi-cyclic peptides.   CordenPharma made a strategic decision to expand their current offering with the manufactur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters